Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries

被引：0
|
作者：
Olina Efthymiadou
机构：
[1] London School of Economics,Medical Technology Research Group, Department of Health Policy
来源：
The European Journal of Health Economics | 2023年 / 24卷
关键词：
Managed entry agreements; HTA decision-making; Conditional reimbursement; Risk-sharing; Discounts;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1023 / 1031
页数：8
相关论文
共 24 条
  • [1] Health technology assessment criteria as drivers of coverage with managed entry agreements: a case study of cancer medicines in four countries
    Efthymiadou, Olina
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2023, 24 (07): : 1023 - 1031
  • [2] Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries
    Efthymiadou, Olina
    Kanavos, Panos
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2021, 37 (01)
  • [3] DETERMINANTS OF FUNDING WITH MANAGED ENTRY AGREEMENTS, AS PART OF HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING PROCESSES: EMPIRICAL EVIDENCE FROM CANCER THERAPIES IN FOUR COUNTRIES
    Efthymiadou, O.
    VALUE IN HEALTH, 2022, 25 (07) : S516 - S516
  • [4] DETERMINANTS OF MANAGED ENTRY AGREEMENTS IN THE CONTEXT OF HTA; EMPIRICAL EVIDENCE FROM ONCOLOGY MEDICINES IN FOUR COUNTRIES.
    Efthymiadou, O.
    VALUE IN HEALTH, 2019, 22 : S513 - S513
  • [5] Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
    Olina Efthymiadou
    Panos Kanavos
    BMC Health Services Research, 22
  • [6] Impact of Managed Entry Agreements on availability of and timely access to medicines: an ex-post evaluation of agreements implemented for oncology therapies in four countries
    Efthymiadou, Olina
    Kanavos, Panos
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [7] USE OF MANAGED ENTRY AGREEMENTS IN INFLAMMATORY DISORDERS AMONG KEY HEALTH TECHNOLOGY ASSESSMENT AGENCIES
    Gupta, P.
    Kumar, T.
    Wahal, V. P.
    Adler, B. N.
    Gupta, J.
    VALUE IN HEALTH, 2018, 21 : S468 - S468
  • [8] Managed Entry Agreements in the Context of Health Technology Assessment Recommendations in Ukraine: Analysis on the Stage of Development
    Khmelovska, M.
    Pinlazhko, O.
    Serediuk, O.
    Malyshevska, I
    Romanenko, I
    Babenko, M.
    Lobas, M.
    Kosyachenko, K.
    VALUE IN HEALTH, 2022, 25 (12) : S337 - S337
  • [9] Adoption of trastuzumab for breast cancer in four emerging countries in the use of health technology assessment: a case study
    Martin-Ruiz, Eva
    Espin Balbino, Jaime
    Lemgruber, Alexandre
    Caro-Martinez, Araceli
    Lessa, Fernanda
    Olry-de-Labry-Lima, Antonio
    Perez-Velasco, Roman
    Garcia-Mochon, Leticia
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (04) : 365 - 373
  • [10] THE FIRST MANAGED ENTRY AGREEMENTS BASED ON HEALTH TECHNOLOGY ASSESSMENT APPROVED IN UKRAINE: ANALYSIS AND FUTURE PERSPECTIVES
    Piniazhko, O.
    Khmelovska, M.
    Serediuk, V
    Malyshevska, I
    Romanenko, I
    Ioltukhovskyi, I.
    Masheiko, A.
    Babenko, M.
    Lobas, M.
    Kosyachenko, K.
    Kahveci, R.
    VALUE IN HEALTH, 2023, 26 (06) : S265 - S265
123